STOCK TITAN

iRhythm (IRTC) CFO receives 8,361 new RSUs in equity grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Wilson Daniel G. reported acquisition or exercise transactions in this Form 4 filing.

iRhythm Holdings, Inc. Chief Financial Officer Daniel G. Wilson reported an equity award of 8,361 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock. Following this grant, his directly held common stock position is 39,055 shares.

According to the terms, 25% of the RSUs vest on March 1, 2027, with an additional 25% vesting on each one-year anniversary thereafter, so long as he continues as a service provider through each vesting date. The filing also notes an additional 100 shares of common stock held indirectly through The Wilson Living Trust dated July 9, 2015, for which Mr. Wilson serves as Trustee.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wilson Daniel G.

(Last) (First) (Middle)
C/O IRHYTHM HOLDINGS, INC.
699 8TH ST #600

(Street)
SAN FRANCISCO CA 94103

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
iRhythm Holdings, Inc. [ IRTC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/25/2026 02/25/2026 A 8,361(1) A $0 39,055 D
Common Stock 100(2) I Held through a Family Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These securities are Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
2. These shares represent an indirect ownership through The Wilson Living Trust dated July 9, 2015, of which Mr. Wilson is the Trustee.
Remarks:
/s/ Marc Rosenbaum, attorney-in-fact 02/27/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did iRhythm (IRTC) report for CFO Daniel G. Wilson?

iRhythm reported that CFO Daniel G. Wilson received an award of 8,361 Restricted Stock Units. Each RSU represents a contingent right to one share of common stock, subject to time-based vesting and continued service conditions over several years.

How do the new RSUs granted to iRhythm (IRTC) CFO vest over time?

The 8,361 RSUs granted to iRhythm’s CFO vest over four years. 25% vest on March 1, 2027, and an additional 25% vest on each one-year anniversary, contingent on his continued service through each vesting date.

Did the iRhythm (IRTC) CFO buy shares on the open market in this Form 4?

No, the Form 4 shows a grant of 8,361 Restricted Stock Units to the CFO, not an open market purchase. RSUs are equity awards that convert into shares over time as vesting conditions are satisfied.

What is the iRhythm (IRTC) CFO’s direct and indirect share ownership after this filing?

After the reported award, the CFO directly holds 39,055 shares of iRhythm common stock. The filing also reports an additional 100 shares held indirectly through The Wilson Living Trust dated July 9, 2015, with Mr. Wilson as Trustee.

What does the zero price per share mean in the iRhythm (IRTC) CFO’s Form 4 grant?

The zero price per share reflects that the 8,361 RSUs were granted as compensation, not purchased for cash. Each RSU converts into one share of common stock only as vesting conditions are met over the specified schedule.
iRhythm Holdings, Inc

NASDAQ:IRTC

IRTC Rankings

IRTC Latest News

IRTC Latest SEC Filings

IRTC Stock Data

4.52B
31.82M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
San Francisco